Teijin Develops High-Performance UV Cutoff Films for Next-Generation Solar Cells

Teijin DuPont Films Japan Limited announced today that it has developed a high-performance polyester film that achieves the world's highest level of protection from ultraviolet (UV) light.

The film is expected to be launched commercially in fiscal 2013 and sales of 2.5 billion yen (31.5 million USD) are envisioned by fiscal 2020. Protective films for electronics materials are expected to be the primary application.

The new film incorporates Teijin DuPont Films' unique technologies for UV absorption agent, and blocks UV radiation up to 390nm, or nearly 100% of all harmful ultraviolet light. Visible light, however, is transmitted at a rate equivalent to or greater than that of conventional films. Until now, the rate of visible light transmission has decreased as UV cutoff performance is increased in conventional films.

UV cutoff properties are incorporated in the film itself, so there is no need for additional coating as required with conventional films. Since impurities generated during coating are eliminated, the new film's production generates just one-tenth the amount of impurities compared to conventional film production, thereby helping to reduce overall costs.

UV cutoff films are used for window glass and films protecting electronics materials. The demand is expected to grow for the protection of high-performance devices such as organic electroluminescent (EL) devices, electronic paper and other next-generation devices, as well as polymer conductive materials in next-generation solar cells and organic semiconductor materials.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.